Geode Capital Management, LLC Jounce Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.9 - $1.85 $86,989 - $178,811	96,655 Added 14.42%	767,117 $1.42 Million
Q4 2022 Feb 13, 2023	BUY	$0.64 - $1.99 $8,435 - $26,228	13,180 Added 2.01%	670,462 $744,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $90,109 - $162,394	33,007 Added 5.29%	657,282 $1.54 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $7.67 $77,448 - $212,152	27,660 Added 4.64%	624,275 $1.89 Million
Q1 2022 May 13, 2022	SELL	$6.01 - $8.54 $157,828 - $224,268	-26,261 Reduced 4.22%	596,615 $4.05 Million
Q4 2021 Feb 11, 2022	BUY	$7.11 - $9.64 $60,051 - $81,419	8,446 Added 1.37%	622,876 $5.2 Million
Q3 2021 Nov 12, 2021	BUY	$5.04 - $8.73 $427,971 - $741,307	84,915 Added 16.04%	614,430 $4.57 Million
Q2 2021 Aug 13, 2021	BUY	$6.58 - $10.66 $1.23 Million - $1.99 Million	186,990 Added 54.59%	529,515 $3.6 Million
Q1 2021 May 12, 2021	BUY	$6.73 - $13.87 $506,217 - $1.04 Million	75,218 Added 28.14%	342,525 $3.52 Million
Q4 2020 Feb 12, 2021	BUY	$6.37 - $10.33 $27,817 - $45,111	4,367 Added 1.66%	267,307 $1.87 Million
Q3 2020 Nov 13, 2020	BUY	$4.58 - $10.95 $76,925 - $183,916	16,796 Added 6.82%	262,940 $2.15 Million
Q2 2020 Aug 13, 2020	SELL	$4.17 - $7.58 $5,771 - $10,490	-1,384 Reduced 0.56%	246,144 $1.7 Million
Q1 2020 May 14, 2020	SELL	$2.91 - $8.7 $36,177 - $108,158	-12,432 Reduced 4.78%	247,528 $1.18 Million
Q4 2019 Feb 13, 2020	BUY	$2.81 - $9.21 $102,699 - $336,607	36,548 Added 16.36%	259,960 $2.27 Million
Q3 2019 Nov 12, 2019	BUY	$3.33 - $4.93 $25,680 - $38,020	7,712 Added 3.58%	223,412 $743,000
Q2 2019 Aug 14, 2019	BUY	$4.3 - $6.73 $66,839 - $104,611	15,544 Added 7.77%	215,700 $1.07 Million
Q1 2019 May 14, 2019	BUY	$3.43 - $6.87 $132,861 - $266,109	38,735 Added 24.0%	200,156 $1.24 Million
Q4 2018 Feb 13, 2019	BUY	$2.69 - $6.71 $55,516 - $138,480	20,638 Added 14.66%	161,421 $543,000
Q3 2018 Nov 13, 2018	BUY	$6.5 - $8.37 $136,552 - $175,836	21,008 Added 17.54%	140,783 $914,000
Q2 2018 Aug 14, 2018	BUY	$7.27 - $21.88 $120,514 - $362,704	16,577 Added 16.06%	119,775 $917,000
Q1 2018 May 15, 2018	BUY	$13.4 - $28.4 $20,649 - $43,764	1,541 Added 1.52%	103,198 $2.31 Million
Q4 2017 Feb 13, 2018	BUY	$12.52 - $17.82 $4,494 - $6,397	359 Added 0.35%	101,657 $1.3 Million
Q3 2017 Nov 14, 2017	BUY	$11.17 - $16.99 $4,155 - $6,320	372 Added 0.37%	101,298 $1.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	100,926	100,926 $1.42 Million

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account